<link rel='stylesheet' href='https//fonts.googleapis.com/css?family=Roboto:400,500,700,400italic|Material+Icons'>
Open Search
MBRX
Moleculin Biotech
$
()


  • Biotech Alert: Searches spiking for these stocks today

    9/26/2024 - 10:50am
  • Biotech Alert: Searches spiking for these stocks today

    9/25/2024 - 10:53am
  • Moleculin Biotech announces presentation of in vivo efficacy data of Annamycin

    9/23/2024 - 08:05am
  • Moleculin Biotech announces first patients treated in Phase 2 tral of WP1066

    9/9/2024 - 08:22am
  • Moleculin Biotech prices $16.5M public offering

    8/16/2024 - 08:37am
  • Moleculin Biotech reports Q2 EPS ($1.70) vs. ($3.02) last year

    8/14/2024 - 08:07am
  • Moleculin Biotech announces plans for MIRACLE Phase 3 pivotal trial

    8/1/2024 - 08:35am
  • Moleculin Biotech files to sell common stock, warrants, no amount given

    7/22/2024 - 17:34pm
  • Moleculin Biotech completes End of Phase 2 meeting with FDA for Annamycin

    7/10/2024 - 08:33am
  • Moleculin Biotech reports data from Phase 1B/2 (MB-106) clinical trial

    6/14/2024 - 08:06am
  • Moleculin Biotech files $200M mixed securities shelf

    6/7/2024 - 17:09pm
  • Moleculin Biotech begins Phase 2 study evaluating WP1066

    5/15/2024 - 08:39am
  • Moleculin Biotech reports Q1 EPS ($2.02) vs. ($4.13) last year

    5/13/2024 - 07:32am
  • Moleculin Biotech announces U.S. patent issue notification for Annamycin

    5/9/2024 - 08:34am
  • Moleculin Biotech reports interim data for Annamycin

    5/7/2024 - 08:58am
dynamic_feed Breaking News